Galena Biopharma (GALE) Reports Q4 Loss of $0.17/Share

Galena Biopharma (NASDAQ: GALE) reported Q4 EPS of ($0.17), versus ($1.33) reported last year.

For earnings history and earnings-related data on Galena Biopharma (GALE) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Reaction roundup: Experts, analysts weigh in on September jobs report
• Piper Sandler on Virtu Financial (VIRT): 'The most overlooked name in our coverage'